Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00906958
Other study ID # 08177-0608
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 11, 2009
Est. completion date June 15, 2009

Study information

Verified date February 2021
Source ResMed
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if the performance of the modified AutoSet device is equivalent or better than the existing AutoSet device (VPAP Auto) in the efficacy of the treatment and the subjective comfort.


Description:

Obstructive sleep apnea (OSA) is characterised by a partial or complete collapse of the upper airway during sleep. The treatment of choice for OSA is Continuous Positive Airway Pressure (CPAP). CPAP acts as a positive airway splint, delivering a fixed or auto adjusted positive pressure to the upper airway via a tube and mask. The modified device to be assessed in this study will act in a similar way to the existing device, VPAP Auto, but utilizes an improved algorithm which should maintain or enhance the effectiveness of the treatment.


Other known NCT identifiers
  • NCT00773396

Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 15, 2009
Est. primary completion date June 15, 2009
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Patients aged 18-80 years - Patients who are on CPAP therapy in AUTOSET mode for no less than 6 months - Patients who are using ResMed masks Exclusion Criteria: - Patients who are unable to provide written informed consent - Patients who are unable to comprehend written and spoken English - Patients who are using Bilevel PAP - Patients who are pregnant - Patients who are suffering any of the following: - Acute respiratory infection - Acute sinusitis, otitis media or perforated eardrum - Pneumothorax or pneumomediastinum - Recent history of severe epistaxis requiring medical attention

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Nexus Flow Generator
The modified device to be assessed in this study will act in a similar way to the existing device, VPAP Auto, but utilises an improved algorithm which should maintain or enhance the effectiveness of the treatment.
VPAP Flow Generator 25
Exiting VPAP Auto 25 Flow Generator with A10 Algorithm

Locations

Country Name City State
Australia Centre for Healthy Sleep Bella Vista New South Wales

Sponsors (1)

Lead Sponsor Collaborator
ResMed

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Apnoea-Hypopnoea Index (AHI) The number of apneas and hypopnoeas per hour of sleep measured on Nexus Auto & VPAP Auto 25 One Night On Each Arm, approximately 8 hours each night
Primary Oxygen Desaturation Index Number of oxygen desaturations per hour of sleep One Night On Each Arm, approximately 8 hours each night
Secondary Comfort of Breathing Participant's Comfort Rating in one question: How comfortable/uncomfortable was the CPAP device to breathe on? Ratings from 0 (very uncomfortable) to 10 (very comfortable) on a Likert Scale One Night On Each Arm, approximately 8 hours each night
Secondary Satisfaction of Treatment Participant's treatment satisfaction in one question: How much did the CPAP disturb your sleep last night? Rating from 0 (a lot) to 10 (not at all) on a Likert Scale One Night On Each Arm, approximately 8 hours each night
Secondary Refreshed Feel Participants rated 0 (not refreshed at all) to 10 (very refreshed) on Likert Scale on one question: How refreshed did you feel this morning? One Night On Each Arm, approximately 8 hours each night
See also
  Status Clinical Trial Phase
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Recruiting NCT03919955 - A Novel Pharmacological Therapy for Obstructive Sleep Apnea Phase 2
Completed NCT03927547 - Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders N/A
Recruiting NCT04007380 - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI N/A
Completed NCT02188498 - Electrocardiography Data Analysis in Sleep Disorders
Completed NCT01503164 - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism N/A
Recruiting NCT00747890 - Surgical Treatment of Mild Obstructive Sleep Apnea N/A
Active, not recruiting NCT00738179 - Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease Phase 3
Completed NCT00841906 - Alice PDx User/Validation Extended Trial N/A
Completed NCT00202501 - Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome N/A
Completed NCT00047463 - Effects of Treating Obstructive Sleep Apnea in Epilepsy Phase 2
Not yet recruiting NCT06029881 - Portable System for Non-intrusive Monitoring of Sleep
Recruiting NCT06093347 - Central Apnoea Monitor Study
Terminated NCT05445869 - Severe OSA Study (SOS) N/A
Withdrawn NCT04096261 - The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
Recruiting NCT04575740 - Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea N/A
Completed NCT04676191 - Validation of a Contactless Vital Signs Measurement Sensor N/A
Recruiting NCT06015620 - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed NCT06051097 - Metabolic Syndrome and Obstructive Sleep Apnea
Completed NCT05687097 - Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury